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Abstract-CDP-diglyceride is converted to phosphatidyl inositol by several particulate 
subcellular fractions of guinea pig brain, with highest specific activity in the microsornal 
fraction. Optimal conditions with respect to pH, metal ion concentration, and substrate 
concentrations have been determined. The reaction was stimulated by the addition of 
bovine serum albumin and by Tween 80. 
Of several DL-CDP-diglycerides synthesized and used as substrates in a spectrophoto- 
metric assay for the enzyme, DL-CDP-didecanoin was the most active. 
The enzyme showed a high selectivity for myo-inositol. Of a number of compounds 
tested, only scyllo-inosose and epi-inosose served as substrates. Three inositol isomers and 
three myo-inositol monophosphates inhibited the reaction slightly. The most potent inhibi- 
tor found was galactinol, a myo-inositol galactoside. 
THE ENZYME CDP-diglyceride : inositol transferase (CDP-diglyceride : inositol 1,2- 
diglyceride phosphotransferase, EC 2.7.8) catalyses the reaction: 
CDP-diglyceride + myo-inositol+ phosphatidyl inositol + CMP 
The occurrence of this reaction in brain is well-documented (AGRANOFF, BRADLEY 
and BRADY, 1958; THOMPSON, STRICKLAND and ROSSITER, 1963). Phosphatidyl 
inositol is the precursor of the di- and tri-phosphoinositides (FOLCH, 1949; BROCKER- 
HOFF and BALLOU, 1962; ROSSITER and PALMER, 1965), which are found predominantly 
in brain (DAWSON and EICHBERG, 1965). The enzymatic conversion of phosphatidyl 
inositol to diphosphoinositide by ATP was demonstrated in brain (COLODZIN and 
KENNEDY, 1964) and in guinea pig liver mitochondria (HAJRA, SEIFFERT and AGRANOFF, 
1965). A recent study of developmental changes in rat brain enzymes concerned with 
inositol lipid metabolism showed that the increase in CDP-diglyceride : inositol 
transferase activity was not associated exclusively with any period of development, 
while phosphatidyl inositol kinase activity rose before myelination, and diphosphoino- 
sitide kinase and triphosphoinositide monoesterase activities rose during myelination 
(SALWAY, HARWOOD, KAI, WHITE and HAWTHORNE, 1968). The rapid turnover of 
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the phosphoinositides during nervous activity points to a special role for their synthe- 
sis and breakdown in brain (HAWTHORNE, 1964; LARRABEE and LEICHT, 1965). The 
role of phosphatidyl inositol in the formation and maintenance of the various special- 
ized membrane structures of brain is also of interest. Recently, WELLS and WELLS 
(1967) reported that the synthesis of both bound inositol and free inositol is inhibited 
in nervous tissue of rats on a high galactose diet, simulating the conditions of galacto- 
semia. ELIASSON, SCARPELLINI and Fox (1967) found decreased levels of the phos- 
phoinositides in the brainstem of rabbits with hereditary cerebellar ataxia; incorpora- 
tion of inositol into these lipids was also decreased in brainstem slices from ataxic 
rabbits below that of controls. In view of the many unanswered questions concerning 
the physiological function of both inositol and the inositol lipids, the objectives of the 
present study were to characterize further the enzyme that incorporates inositol into 
lipid in brain and to determine the effects of various polyols and related compounds 
on the reaction. 
MATERIALS A N D  M E T H O D S  
Chromatography systems. System A was used to separate and identify intermediates in the chemi- 
cal synthesis of CDP-diglycerides. Thin-layer plates were prepared from a slurry of silica gel without 
binder (Kieselgel, Arthur Thomas Company) in 1 x M-Na,CO,. The developing solvent was 
hexane-ether (1 : 1,  v/v). Spots were detected with bromothymol blue, phosphate (DITTMER and 
LESTER, 1964), or hydroxamate (TATE and BISHOP, 1962) spray. The following RR values were 
observed : 
Fatty acid chlorides 0.90 
Glycerol benzyl ether 0-75 
Diglycerides 0.30 
Phosphatidic acid diphenyl esters 0.45 
Phosphatidic acid 0 
System B was used to se arate brain phospholipids and also various sugars and cyclitols. Thin- 
layer plates were prepared gom Silica Gel G. The developing solvent was chloroform-methanol- 
acetic acid-water (50:25: 7:  3, by vol.). Lipids were detected with bromothymol blue or phosphate 
spray. The sugars and cyclitols were detected with silver nitrate spray (WALDI, 1965). 
System C was used to separate and identify phosphatidic acid, CDP-diglyceride, and phosphatidyl 
inositol. Formaldehyde-treated paper was prepared as described by HORHAMMER, WAGNER and 
RICHTER (1959) with the modification of HENDRICKSON and BALLOU (1964). The papers were de- 
veloped in a descending system for 10-14 hr with n-butanol-acetic acid-water (4: 1 : 1, by vol.). Spots 
were visualized by dipping the papers in 0.005 % Rhodainine 6G and viewing under ultra-violet light. 
Chemicalsynthesis of CDP-diglycerides. DL-Benzyl glycerol ether was synthesized from DL-acetone 
glycerol as described by SOWDEN and FISCHER (1941). This product was condensed with palmitoyl 
chloride, docosanoyl chloride, or eicosanoyl chloride as described by SOWDEN and FISCHER (1941) 
to give the corresponding diglycerides. Didecanoin was synthesized from DL-acetone glycerol as 
described by BAER and MAHADEVAN (1959). DL-Phosphatidic acid was prepared from each di- 
glyceride by condensation with diphenylphosphorochloridate and subsequent reduction with platinum 
oxide to remove the diphenyl ester group, following the method of BAER (1951). These phosphatidic 
acids were stored as the disodiurn salts at -20" in uacuo. Phosphatidic acid (Caz+ salt) was prepared 
from egg lecithin by a procedure of KATES (personal communication) with cabbage phospholipase D 
(Calbiochem, Los Angeles). Methods of isolation or crystallization of all these various intermediates 
differed slightly depending on the chain length of the fatty acid. CDP-diglycerides were prepared by 
converting the phosphatidic acids to the free acid form and condensing them with CMP-morpholidate 
according to the method Of AORANOFP and SUOMI (1963). The CDP-diglycerides containing palmitic, 
docosanoic, or eicosanoic acids were isolated by the partition method (AGRANOFF and SUOMI, 1963). 
The CDP-diglycerides from didecanoin or egg lecithin were isolated on silicic acid columns as des- 
cribed below for the didecanoyl compound. Purity of all these compounds was checked by chroma- 
tography in System A or System C, by quantitative hydroxamate determinations (SNYDER and 
STEPHENS, 1959), and, where appropriate, by quantitative phosphate determinations (BARTLEIT, 
1959). Cytidine content in the CDP-diglycerides was determined spectrophotometrically. 
To prepare CDP-DL-didecanoin, a mixture of 5.54 ml of DL-benzyl glycerol ether, 5.35 ml of dry 
pyridine, and 26.0 ml of benzene was added gradually with stirring to 12.72 ml of chilled decanoyl 
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chloride in a flask stoppered with a drying tube. After 18 hr at 31", the product was isolated as 
described by BAER and MAHADEVAN (1959). The final ether solution was evaporated to a volume of 
15 ml on a rotary evaporator. Upon addition of 5 ml of acetone and chilling in an acetone-dry ice 
bath, a heavy white precipitate appeared, This was dried to constant weight in vacuo at -20". Yield: 
141 g (90 per cent) of didecanoyl benzyl ether. Acyl ester content: 94 per cent of theoretical. 
Chromatography in System B showed the presence of a trace of benzyl glycerol ether in addition to 
the product, Rp 0.75. 
The above product was shaken vigorously with 12 ml of glacial acetic acid and 2.5 g of palla- 
dium black in an atmos here of hydrogen at 15 Ib/in8. After absorption of hydrogen ceased (1.5 hr), 
40 ml of ether were ad&d. The catalyst was sedimented by centrifugation and washed once with 20 
ml of acetone. The supernatants were concentrated to a small constant volume on a rotary evapo- 
rator and dried in vacuo. The liquid was chilled to O", and large white crystals appeared. These were 
collected by centrifugation, recrystallized from a small volume of hexaneether (1 : 1,  v/v), and dried to 
constant weight in uacuo. Yield: 7.76 g (67 per cent) of DL-didecanoin, m.p.: 25-30'. Acyl ester 
content: 97 per cent of theoretical. Chromatogra hy in System B showed a single spot, Rp 0.3. 
A solution of 7.56 g of DL-didecanoin in 50 my of dry pyridine was added slowly to 296 ml of 
diphenylphosphorochloridate in 50 ml of dry pyridine. After 20 hr at 30", the product was isolated 
as described by BAER (1951). The final ether solution was evaporated to give 10.5 g of an oily, slightly 
yellow liquid. This was dissolved in 35 ml of absolute ethanol and kept at -20" overnight. The dense 
white crystals were collected on a sintered glass funnel at -20". The mother liquor was evaporated 
to 20 ml, and a second batch of crystals was obtained. The batches were combined, recrystallized 
twice in ethanol, and dried to constant weight in vacuo. Yield: 8-39 g (70 per cent) of didecanoin-DL- 
glycerophosphoric acid diphenyl ester. Ratio of acyl ester:P was 0-96. Chromatography in System 
A gave a single spot, RF 0.45. 
To remove the diphenyl ester group, a mixture of 7.39 g of the above product with 1.5 g of plati- 
num oxide and 100 ml of glacial acetic acid was stirred vigorously under Hs gas. The catalyst was 
sedimented by centrifugation, and the supernatant solution was evaporated to a small volume. This 
was dried to constant weight in uacuo to give an oily liquid. Yield: 4.56 g (70 per cent) of didecanoyl- 
DL-phosphatidic acid. Ratio of acyl ester:P was 0.98. Chromatography in System A showed a major 
spot at the origin with a trace of didecanoin, Rp 0.30. 
CDP-DL-didecanoin was synthesized by condensation of 0.71 g of didecanoyl-DL-phosphatidic 
acid with 1.1 1 g of CMP-morpholidate (Calbiochem). The isolation procedure described for CDP- 
dipalmitin (AGRANOFF and SUOM, 1963) was not suitable for CDP-didecanoin owing to the greater 
solubility of the latter compound in methanol at low pH during the first partition step. After evapora- 
tion of pyridine from the reaction mixture, 45 ml of chilled chloroform were added to the residue, 
followed by enough 0.88 % formic acid (about 1 ml) to bring the pH to 3.5 (pH paper). The mixture 
was transferred to a 50 ml ground glass-stoppered centrifuge tube and washed three times with 10 ml 
of 0-88 % formic acid. Acidification and washing steps were done at 0-4". The chloroform solution 
was concentrated to about 2 ml on a rotary evaporator with several additions of benzene to reduce 
foaming. The mixture was freeze-dried from benzene, taken up in 3 ml of chloroform, and placed 
on a Unisil column (17.5 g of Unisil in chloroform). 
Stepwise elution was carried out with 200 ml of chloroform, then chloroform-methanol in the 
proportions of 95:5,9: 1,8:2, and 7:3. Most of the CDP-didecanoin was in the last fraction, along 
with a trace of phosphatidic acid, as determined by chromatography in System C. This fraction was 
concentrated and freeze-dried from benzene and washed with ether containing methanolic ammonium 
hydroxide to remove phosphatidic acid. The residue was again freeze-dried from benzene. Yield: 
0.58 g (50 per cent) of DL-CDP-didecanoin as the diammonium salt. Ratio of acyl ester:P:cytidine: 
2.13:2-00:1*91. Chromatography in System C gave a single spot with RF 0.45. 
Preparation of subcellular fractionh. For initial studies on subcellular localization of transferase 
activity, whole brains from adult male guinea pigs were homogenized in 4 vol. of 0.25 M-sucrose 
with an all-glass homogenizer. After centrifugation at 900 g for 10 min, the supernatant fraction was 
decanted and centrifuged at 12,000 g for 20 min to give a crude mitochondria1 pellet. The resulting 
supernatant was centrifuged at 76,000 g for 80 min in the 40 rotor of a Spinco ultra-centrifuge to give 
a microsomal pellet. The pellets were resuspended in 0.25 M-sucrose by brief homogenization, and 
all fractions were dialysed overnight against 4 1. of 0.07 M-potassium phosphate buffer (pH 8.1) with 
one change of buffer. For subsequent experiments, the total homogenate was first dialysed, then 
centrifuged as above. The pellet resulting from the final centrifugation was resuspended in 0.25 M- 
sucrose (8 ml/g wet wt. of brain). In this form, the preparation could be stored at -20" for several 
months with little loss of activity. In all studies except those of subcellular localization the stored 
enzyme preparation wa9 used. 
Protein in the homogenates and subcellular fractions was determined by the method of LOWRY, 
ROSEBROUGH, FARR and RANDALL (1951). 
Assays for CDP-diglyceride: inositol transferase. Transferase activity was measured by determining 
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the amount of CMP released from CDP-diglyceride (PAULUS and KENNEDY, 1960; AGRANOFF and 
BRADLEY, 1961). In initial experiments, the following large-scale assay, referred to  hereafter as 
Assay A, was used. Incubation mixtures contained 350 nmoles of DL-CDP-didecanoin, 350 pmoles 
of tris-HC1 buffer (pH 8*1), 1750 nmoles of myo-inositol, and 35 pmoles of MgCI, in a total volume 
of 2.0 ml. An incubation mixture without inositol served as a control to  indicate release of CMP 
which was not dependent on the transferase. The CDP-diglyceride was added to the incubation tube 
in chloroform, dried with a stream of nitrogen, and suspended with buffer, inositol, and MgCl, by 
gentle sonication. In most experiments, bovine serum albumin was added to give a concentration of 
5 mg/ml. The incubation mixtures were chilled, and enzyme was added. A portion was removed 
immediately, and the remainder was incubated at 37". For each time point, 0.6 ml of the incubation 
mixture was pipetted into 1.0 ml of cold 7 % TCA. After centrifugation, the pellet was washed once 
with 1.0 ml of 7 % TCA. The TCA supernatants were combined and brought to a total volume of 
3-0 ml with TCA. The amount of CMP released was determined spectrophotometrically by using the 
difference between the readings at 280 mp and 310 m,u. A molar absorbancy of 13 x lo6 mole-' ,ma 
was used to calculate the amount of CMP. The difference in values between samples with and without 
inositol was used to calculate transferase activity. 
A small scale assay (Assay B) was used in later experiments. Incubation mixtures contained 
35 nmoles of DL-CDP-didecanoin, 35 pmoles of Tris-HC1 buffer (pH 8.3), 280 nmoles of myo- 
inositol and 10.5 pmoles of MgCl, in a total volume of 0.2 ml. In most experiments, albumin was 
added as indicated. The analysis was the same as Assay A, except that a separate tube was prepared 
for each time point. A 0.4 ml portion of 7 % perchloric acid was added to stop the reaction, and the 
supernatant fraction was assayed directly. 
In experiments comparing the release of CMP with the incorporation of inositol into lipid, 
incubation mixtures were prepared as for Assay B, except twice the usual amounts were used, and 
[2-SH]myo-inositol (1.9 pc/pmole) was substituted for unlabelled inositol. The final volume was 
0-4 ml. After incubation, half of the sample was pipetted into perchloric acid as described above for 
the determination of CMP. Lipids were extracted from the remaining 0.2 ml by a modification of a 
procedure described by BLIGH and DYER (1959). An additional 0.2 ml of water was added, followed 
by 1.5 ml of chloroform-methanol (1 :2, v/v), 100 pg of purified soybean phosphatidyl inositol, and 
30 ,ul of concentrated HCI. After thorough mixing, another 0.5 ml of chloroform was added, followed 
by 0.5 ml of 2 M-KCI containing 0.2 M-inositol. After mixing and centrifugation, the lower layer was 
transferred to another tube with a capillary pipette. The upper layer was treated again with 1 ml of 
lower layer. The combined lower layers were washed three times with 1 ml portions of KC1-inositol. 
The lipid extracts were dried in counting vials and dissolved in 10 ml of scintillation fluid containing 
0.5 % PPO (2,5-diphenyloxazole) and 0.03 % POPOP (1,4-bis-2(5-phenyloxaolyl)-benzene) in 
toluene-methanol (19: 1, v/v). 
Materials. Bovine serum albumin, Fraction V, was purchased from Armour, Chicago, Illinois. 
Detergents were obtained from several sources: sodium deoxycholate from Mann Research 
Laboratories, New York; Triton X-100 from Rohm and Haas, Philadelphia, Pennsylvania; Tween 
80 and Tween 20 from Atlas Chemical Industries, Wilmington, Delaware; and Cutscum from Fischer 
Scientific Company, Chicago, Illinois. Sodium [3H]borohydride was purchased from New England 
Nuclear Corporation, Boston, Massachusetts. PPO and POPOP were purchased from Packard 
Instrument Company, LaGrange, Illinois. 
The following cyclitols were the generous gift of Dr. Laurens Anderson: the muco-, epi-, neo-, 
and scyllo-isomers of inositol; hydroxyisomytilitol (2-C-hydroxymethyl-myo-inositol); 2-0,C- 
methylene-myo-inositol ; D-myo-inosose-1 ; the cyclohexanepentols (+)-quercitol and scyllo- 
quercitol; conduritol A; the 0-methyl ethers (+)-pinitol, (-)-quebrachitol, bornesitol, sequoyitol, 
and dambonitol ; the amino derivatives scyllo-inosamine, neo-inosamine-HCl, and streptamine; the 
2-acetamido- and (&)-Cacetamido derivatives of myo-inositol. 
Several cyclitols were contributed by Dr. S. J. Angyal: the hexa-acetate derivatives of cis-, allo-, 
and muco-inositols and the tri-0-cyclohexylidine derivatives of epi- and neo-inositols. The derivatives 
were converted to their free form by acid hydrolysis. 
~~-Epi-inosose-2 was the gift of Dr. Theodore Posternak. [2-8H]Myo-inositol was obtained by 
catalytic hydrogenation of the inosose (POSTERNAK, SCHOPFER and REYMOND, 1955; BENJAMINS, 
1967). Myo-inositol-L-1-phosphate, myo-inositol-~-3-phosphate (dicyclohexylammonium salt) and 
myo-inositol-~~-4 phosphate were the gifts of Dr. Clinton Ballou. 
Scyllo-inosose, glucitol, and DL-a-glycerol-phosphate were purchased from Sigma Chemical 
Company, St. Louis. Leuo-inositol-3-phosphate, myo-inositol-2-phosphate, galactinol (1-0-a,D- 
galactopyranosyl-~-3-myo-inositol), and both D- and L-serine were purchased from Calbiochem, Los 
Angeles. Galactitol, D-galactonolactone, and Cerythritol were obtained from Mann Research 
Laboratories, New York. D-Galactose, 2-aminoethanol, and cyclohexylamine were purchased from 
Eastman, Rochester, New York, choline chloride was purchased from Merck, Rahway, New Jersey; 
and D-glucose from Allied Chemical, New York, 
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RESULTS 
CDP-diglyceride : inositol transferase activity in dialysed homogenates of various 
guineapig organs. The specific activity of the transferase was highest in heart and 
lung, while liver had the greatest total activity and lowest specific activity (Table 1). 
Liver was especially active in releasing CMP from CDP-diglyceride without added 
inositol. Since these preparations were well-dialysed, this may represent enzymatic 
hydrolysis of CDP-diglyceride to CMP or CDP. 
TABLE l.-’hANSFERASE ACTIVITY IN DIALYSED HOMOGENATES OF VARIOUS GUINEA PIG ORGANS 
Total activity/ 
Wet wt. Protein organ Specific activity 
Organ (&-9 (mglg wet w.1 (units) (unitslmg protein) 
Brain 4.2 97 19,200 49(19) 
Liver 19.7 152 92,500 31(37) 
Kidney 4.2 148 19,200 31(17) 
Heart 1 *9 108 17,300 76(15) 
Lung 4.7 100 36,000 76(12) 
Spleen 1.1 145 10,100 64(12) 
Homogenates were prepared from similar amounts of each tissue and dialysed over night. Assay 
A was used, without bovine serum albumin. Values obtained when inositol was omitted are shown 
in brackets. CMP release in the presence of inositol minus CMP release without added inositol is 
considered transferase activity. One enzyme unit is that quantity of enzyme which releases 1 nmole 
of CMP in 1 hr. The values for protein and enzyme activity represent the means of duplicate deter- 
minations. 
Localization of transferase activity in subcellular fractions of guinea pig brain, 
Initial studies on the localization of transferase activity gave variable results. In an 
effort to obtain more reproducible values, bovine serum albumin was added to each 
incubation mixture. This stimulated activity in all fractions to some extent, but especi- 
ally in the pellet obtained after centrifugation at 76,000 g .  Thereafter, all fractions 
were assayed in the presence of bovine serum albumin at  a concentration of 5 mg/ml, 
unless otherwise noted. Of the total activity in the homogenate, 25-30 per cent could 
be recovered in each of the crude particulate fractions sedimented at 900 g, 12,000 g, 
and 76,OOOg. Less than 5 per cent of the activity was recovered in the final super- 
natant fraction. The microsomal fraction (76,000 g pellet) had the highest specific 
activity, followed by the crude mitochondrial fraction (12,000 g pellet). 
Dialysis of the total homogenate before preparation of the crude subcellular 
fractions resulted in an increase in both the total and specific activities of the transfer- 
ase recovered in the 76,000 g fraction (Table 2). Dialysis before centrifugation reduced 
the amount of protein in this fraction to one-third of that obtained in the pellet 
dialysed after centrifugation. At the same time, the total activity in this pellet was 
increased 1.5 times. Consequently, this method was used to prepare the transferase 
for further characterization. 
Fractionation of a crude mitochondrial preparation on a discontinuous sucrose 
density gradient (DE ROBERTIS, PELLEGRINO DE IRALDI, RODRIGUEZ DE LOREZ ARNAIZ 
and SALGANICOFF, 1962) indicated that none of the submitochondrial fractions is 
enriched in transferase activity. Fraction A, identified in the studies of DE ROBERTIS 
et al. (1962) as primarily myelin fragments, had a markedly lower specific activity than 
the other fractions. The crude mitochondrial fraction, the bands presumably enriched 
in nerve endings, and the final mitochondrial pellet all had similar specific activities. 
4 
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TABLE 2.-DISTIUBUTION OF TRANSFERASE ACTIVITY IN BRAIN 
Fraction 
Protein Total activity Specific activity 
(m& (units) (unitslmg protein) 
Centrifuged before dialysis 
Whole homogenate 369.0 46,000 125 
12,000 g fraction 116.0 16,500 142 
76,000 g fraction 45.7 14,100 309 
Whole homogenate 338.0 52,800 156 
12,000 g fraction 130.0 24,000 276 
76,000 g fraction 15.4 21,700 1400 
A brain was homogenized in 9 vol. of 0.25 M-Sucrose. One-half was centrifuged immediately 
(see Methods) and all fractions were dialysed. The rest of the homogenate was first dialysed, then 
centrifuged to prepare the subcellular fractions. Assay A was used, with bovine serum albumin 
(5mglml) added. The values for protein and enzyme activity represent the means of duplicate 
determinations. 
Centrifuged after dialysis 
20 - CDP-DIDECANOI N 
15 - 
10 20 30 
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FIG. 1 .-Stoichiometry of CMP release and incorporation of [2-aH]myo-inositol. 
Microsomal fraction prepared from homogenates of brain after dialysis was incubated as 
described for Assay B, with bovine serum albumin (5 mglml). The solid lines indicate 
CMP release and the dotted lines inositol incorporation into lipid. The data are from a 
single typical experiment; each point represents the mean of duplicate determinations. 
Stoichiornetry of CMP release and incorporation of inositol into lipid. In the reac- 
tion catalysed by CDP-diglyceride : inositol transferase, one mole of myo-inositol was 
incorporated into phosphatidyl inositol for each mole of CMP released from CDP- 
diglyceride (Fig. 1). In these experiments, [2-3H]myo-inositol was used, and release 
of CMP and synthesis of radioactive lipid were measured in duplicate samples of the 
same incubation mixtures. The exchange of inositol described by PAULUS and 
KENNEDY (1960) at high Mn2+ concentrations with chick liver microsomal fractions 
did not occur in these brain microsomal fractions with the assay conditions used. 
In another experiment, with unlabelled myo-inositol, the conversion of CDP- 
diglyceride to phosphatidyl inositol was demonstrated by extraction of lipids and 
chromatography on formaldehyde-treated paper (System C). The amount of CMP 
released indicated that half of the DL-CDP-didecanoin, presumably the L-isomer, 
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FIG. 2.--Comparison of three synthetic CDP-diglycerides as substrates. Conditions 
as in Fig. 1. Twice as much enzyme was used to obtain the two lower curves. (a) 37.5 
moles  of m-CDP-didecanoin; (b) 37.5 nmoles of CDP-diglyceride prepared from egg 
lecithin; (c) 37.5 moles  of DL-CDP-dipalmitin. Each point represents the mean of 
duplicate determinations. Assay B was used, with a total volume of 0.2 ml. 
had reacted. The chromatogram showed about half of the CDP-diglyceride remaining, 
compared to the unincubated sample. A new spot appeared with an RF corresponding 
to that of phosphatidyl inositol. 
Efect of fatty acid composition of CDP-diglyceride on transferase activity. Initial 
studies indicated that DL-CDP-didecanion was a better substrate than DL-CDP- 
dipalmitin or CDP-diglyceride from egg lecithin (Fig. 2). No reaction was observed 
with DL-CDP-diglycerides containing C, or C,, fatty acids under the conditions of 
Assay B. Omission of bovine serum albumin or replacement of the albumin with 
Tween 80 or Cutscum at several concentrations did not stimulate the reaction with 
the longer chain CDP-diglycerides nor did substitution of Mn2+ for Mg2+. Addition 
of egg lecithin to give a concentration of 2.5 mg/ml inhibited the reaction with CDP- 
dipalmitin by about 25 per cent, and that with CDP-diglyceride from egg lecithin by 
about 90 per cent. 
Optimal conditions for conversion of DL-CDP-didecanoin to phosphatidyl inositol. 
The rate of the transferase reaction was proportional to the amount of enzyme added 
over a range of 6 to 160 pg of proteinlml of incubation medium. The optimal pH was 
8.6 (Fig. 3). Although Mn2+ stimulated best at low concentrations, it had a very 
sharp optimum (Fig. 4). Maximal stimulation with Mn2+ under these conditions was 
about two thirds of that obtained with higher concentrations of Mg2+. Addition of 
EDTA abolished transferase activity. Caa+ had no effect on the rate in the presence 
of Mg2+. Other metals were not tested. 
The apparent K,,, of myo-inositol in this reaction was determined by following 
either the amount of CMP released or the amount of labelled inositol incorporated 
(Fig. 5). Similar values, around 1-5 x M, were found in both cases. The Line- 
weaver-Burk plot was obtained by following the incorporation of labelled inositol 
into lipid, as described for the stoichiometry experiments. 
When the effects of varying concentrations of CDP-didecanoin and CDP-dipal- 
mitin were studied, CDP-didecanoin appeared to be inhibitory at concentrations above 
187 nmoles/ml (Fig. 6). Apparent K,,, values obtained were 1-7 x lo4 M for DL-CDP- 
didecanoin and 5.9 x lo4 M for DL-CDP-dipalmitin. 
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In the initial experiments on subcellular fractionation, bovine serum albumin 
consistently stimulated the microsomal fraction, but the degree of stimulation varied 
from three- to eight-fold. In  later experiments with enzyme prepared after dialysis, 
the degree of stimulation was more constant (Fig. 7). With the optimal concentration 
of albumin, 5 mg/ml, a four- to five-fold stimulation was generally observed. 
Various detergents were tested in the absence of bovine serum albumin to  determine 
their effects on the transferase reaction. Cutscum, deoxycholate , and Triton X-100 
at  concentrations from 0.50 to 0.05 mg/ml had little effect on the reaction with CDP- 
didecanoin as substrate. Deoxycholate at the highest concentration inhibited slightly. 
1 I I I 
7 8 9 
PH 
FIG. 3.-Effect of pH. Conditions as in Fig. 1 ,  
except unlabelled inositol and Assay A were 
used. Tris-HC1 buffers were used; a similar 
optimum was observed with glycine-NaOH 
buffers. Each point represents the mean of 
duplicate determinations. 
Mn'+ l+...: , , , 
20 40 60 80 
Mg" or Mn", pmoles/ml 
FIG. 4.-Effect of Mga+ and Mna+ concentra- 
tions. Conditions as in Fig. 3. Each point 
represents themean of duplicatedeterminations. 
Higher amounts of these detergents interfered with the spectrophotometric assay. 
Tween 20 inhibited the reaction by 40 per cent at a concentration of 5 mg/ml, but gave 
a two-fold stimulation at both 0.10 and 0.05 mg/ml. Tween 80 was the most effective 
detergent found, and its effect on transferase activity was studied over a wide range of 
concentrations, from 5 mg/ml to 5 x mg/ml. At the higher concentrations, 
there was less transferase activity than that observed in the absence of detergent or 
albumin. At 5 x mg/ml, it stimulated activity almost as muchasoptimalamounts 
of albumin (5 mglml). With Tween 80 at a concentration of 5 x mg/ml, there 
was still a two-fold stimulation of activity. Preliminary experiments with Tween 80 
at  a concentration of 0.50 mg/ml indicated that it may act in part by solubilizing some 
of the microsomal membrane. When microsomal fraction was suspended in 0.25 M- 
sucrose and Tween 80 and held at 0-4" for 90 min, 30 per cent of the activity was 
recovered in the supernatant obtained following centrifugation at 76,000 g for 60 min. 
No release of enzyme activity into the supernatant was observed in similar experiments 
in which the microsomal fraction was frozen and thawed repeatedly, exposed to low 
ionic strength buffers, sonicated, or mixed with the other detergents mentioned above, 
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f x i d  
FIG. 5.-Apparent X;. of ntyu-inositol. Conditions as in Fig. 1. Incubations were 
terminated after 10 min, and the amount of [2-SH]myo-inositol incorporated into lipid 
was determined. The data are from a single typical experiment; each point represents 
the mean of duplicate determinations. 
I 
S 
FIG. 6.-Apparent K,,, of DL-CDP-didecanoin and DL-CDP-dipahitin. Conditions 
as in Fig. 1, except unlabelled inositol was used. For DL-CDP-didecanoin (-0-O-h 
incubations were terminated after 2.5 min, and for DL-CDP-dipahitin (-0-0-1, 
after 10 min. The data are from a single typical experiment; each point represents the 
mean of duplicate determinations. 
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TABLE 3.4uBsTRATBs AND INHIBITORS OF THE TRANSPERASE REACTION 
Incorporation Inhibition 
Substrates ( %) Inhibitors ( %) 
epi-inosose (myo-inosose4) 10 cis-inositol 40 
myo-inositol-~-3-phosphate 35 
myo-inositol 100 galac tinol 50 




Other compounds tested as substrates or inhibitors and found to be inactive 
or of questionable activity 




u'extro-inositol bornesitol (DL-1-0-methyl-myo-inositol) 






Miscellaneous Other cyclitols 
glucitolt. quercitol (1,3,4/2,5 cyclohexanepentol) 
galactitol$ scylfo-quercitol 
D-glucose$ conduritol 
D-galactose$ quebrachitol (1-0-methyl-leuo-inositol) 




L-serine streptamine (1,3-aminodeoxy-scyllo-inositol) 
2-aminoethanol 
choline chloride 
Rates given are relative to myo-inositol in the absence of other substrates or inhibitors. 
Compounds tested as possible substrates were substituted for myo-inositol in Assay B at a concen- 
tration of 2.8 ,umoles/ml. To test for inhibition, the compound and myo-inositol were both added to 
the incubation mixture at a concentration of 1-4 ,umoles/ml. In each case, samples with the same 
concentration of myo-inositol alone were incubated simultaneously. The reactions were stopped 
after 0, 5, 10, and 15 min, and the rates compared. Because of the limits of the sensitivity of the 
assay and the detection of minor impurities in the compounds, changes in rate of less than 3 per cent 
were not considered significant. If the change in rate was between 3 and 7 per cent, the effect was 
still considered questionable. The results for epi-inosose and scyllo-inosose represent the means of 
six experiments. The phosphates which inhibited were tested twice, and the other inhibitors three 
times. 
* Questionable substrate. 
t Questionable inhibitor. 
$ Not tested as substrate. 
PAULUS and KENNEDY (1960) reported that these two inososes were about 25 per cent 
as active as myo-inositol with enzyme prepared from frozen chick livers; they used a 
similar spectrophotometric assay and also p4C 1-epi-inosose. Similar results were 
obtained in the present studies with enyzme from frozen chicken liver. With both 
chicken liver and guinea pig brain, the apparent incorporation of epi- and scyllo- 
inosose was verified in the present study by treating the lipid obtained following 






FIG. 9.-Inhibition kinetics of galactinol. Conditions as for Fig. 1 ,  except unlabelled 
myo-inositol was used. Theconcentration wasvaried from 0.35 to l.lOpmoles/ml (lower 
curve). The upper curve shows the results obtained when galactinol (1-4 pmoles/ml) 
was added. Each point represents the mean of duplicate determinations. 
incubation with tritium-labelled sodium borohydride. A labelled lipid with chromato- 
graphic properties similar to phosphatidyl inositol was recovered from incubation 
mixtures containing either inosose, but not from unincubated inosose or incubation 
mixtures containing myo-inositol. 
The compounds that inhibited the reaction were studied to determine the type of 
inhibition involved. Limited amounts (5-20 mg) of the cyclitols were available, so 
extensive studies were not possible. In these studies, the concentration of myo- 
inositol was varied, while that of the inhibitor was held constant. Galactinol showed 
non-competitive inhibition kinetics (Fig. 9). Smaller effects were seen with epi-, 
scyllo- and cis-inositol as well as the three myo-inositol monophosphates which 
inhibited. Both the Km and YmaX appeared to be affected by these compounds. 
Since WELLS and WELLS (1967) reported that galactitol inhibited the conversion 
of phosphatidic acid to phosphatidyl inositol, the effects of this compound on the 
transferase reaction were examined in more detail. Galactose was used in these experi- 
ments for comparison. At concentrations 30 times that of my-inositol, a very slight 
inhibition (about 5 per cent) was observed with both compounds. Preincubation of 
the enzyme with galactitol before addition of enzyme had no effect. 
DISCUSSION 
Studies on the distribution of CDP-diglyceride : inositol transferase activity in 
several guinea pig organs (Table 1) showed that the specific activities in the six tissues 
studied were similar. The greatest total activity was observed in liver, followed by 
lung, brain and kidney, heart and spleen. This can be compared with the data reported 
by AGRANOFF et al. (1958) for the incorporation of [2-3H]myo-inositol in guinea pig 
in uiuo. Total incorporation of radioactivity into a chloroform-methanol soluble 
fraction was greatest in liver, in agreement with the present spectrophotometric 
in fiitro study. However, kidney had four times as much activity as lung in vivo. 
Heart and spleen had low activities, but the value for brain was very low, compared to 
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the present study. These differences may be due to differences in uptake and to dilu- 
tion with endogenous pools in uiuo. 
CDP-diglyceride has been isolated from tissues only after preincubation with 
labelled precursors and addition of synthetic carrier, so that no information concern- 
ing its fatty acid substituents is presently available. The fatty acid content of phos- 
phatidyl inositol from all tissues studied includes high amounts of stearic acid and 
arachidonic acid (HENDRICKSON and BALLOU, 1964; GLENDE and CORNATZER, 1966). 
This could very well resemble the fatty acid-content of naturally occurring CDP- 
diglyceride. Synthesis of CDP-diglyceride from egg lecithin provided a substrate with 
unsaturated fatty acids in the 2-position. The reported fatty acid content of egg leci- 
thin is 36 per cent palmitic acid, 14 per cent stearic acid, 36 per cent linoleic acid and 
14 per cent linolenic acid (TATTRIE, 1960). The observation in these studies that de- 
canoate gives the higher activity suggests that the physical state of the substrate is of 
overriding importance in the in vitro system. 
CDP-diglyceride : inositol transferase from guinea pig brain is similar to enzyme 
from other sources. The high pH optimum (8.6) may be compared to the optimum 
of 8.0 reported by PAULUS and KENNEDY (1960) for the synthesis of phosphatidyl 
inositol in a microsomal fraction from chick liver, with CDP-dipalmitin as substrate, 
PROTTEY and HAWTHORNE (1967) reported an optimal pH of 7.5 for the transferase in 
a microsomal fraction from guinea pig pancreas, with CDP-diglyceride prepared from 
bovine brain lecithin as substrate. In contrast to the results reported for chick liver 
or guinea pig pancreas, Mg2+ stimulates the transferase from brain to a greater extent 
than Mn2+. PROTTEY and HAWTHORNE (1967) reported that bovine serum albumin 
stimulated the transferase from pancreas, as well as the acylation of a-glycerol- 
phosphate. The albumin may stimulate by removing inhibitory fatty acids as they 
suggest, or may exert a ‘detergent-like’ effect, allowing more effective combination of 
enzyme and substrates. The ratio of albumin to microsomal protein was about 20: 1 
in both the pancreas and present brain studies. 
The cyclitol specificity of CDP-diglyceride : inositol transferase was first investi- 
gated by PAULUS and KENNEDY (1960) in a microsomal fraction from chicken liver, 
also using a spectrophotometric assay. Of the five cyclitols tested, dextro-inositol, 
Zeuo-inositol, and pinitol had no activity as substrates while scyllo-inosose and DL-epi- 
inosose-2 each showed about 25 per cent as much activity as myo-inositol. L-Serine, 
choline, ethanolamine, glycerol, glucitol, L-iditol, D-mannitol, and ribitol had no 
activity in an assay in which the release of labelled CMP from cytidine-r2P]-P- 
dipalmitin was measured. 
In the present study, a large number of compounds was tested both as substrate 
and inhibitors of the transferase reaction in the microsomal fraction of guinea pig 
brain. The results show that the transferase is highly specific for myo-inositol, in 
agreement with the tissue culture studies Of EAGLE, OYAMA, LEVY and FREEMAN (1957), 
who demonstrated specificity for myo-inositol in maintenance of culture growth. 
Inosose and ~~-epi-inosose-2 could be demonstrated to serve as substrates in place of 
myo-inositol with the brain enzyme. Verification of the formation and possible 
occurrence of phosphatidyl inososes in brain would, of course, require isolation and 
identification of these compounds. Scyllo-inosose (myo-inosose-2) was found in rat 
sciatic nerve and calf brain (SHERMAN, STEWART, SIMPSON and GOODWIN, 1968). 
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Another possible substrate might be 2-C-hydroxy-methyl-myo-inositol, since WEIN- 
HOLD (1961) observed that this cyclitol derivative is incorporated into the lipid fraction 
of a number of organs in rat in vivo, although incorporation into brain lipids was not 
examined. This compound neither inhibited nor served as a substrate in the present 
study. 
With guinea pig brain transferase, several compounds inhibited the incorporation 
of myo-inositol into lipid. The isomers of myo-inositol which were inhibitory were 
cis-, epi- and scyllo-inositol. These isomers differ from the five that did not inhibit 
in that they possess axial hydroxyls on only one side of the ring as does myo-inositol, 
a property which could allow a closer approach to the site of reaction on the enzyme 
than other inositols. 
The most potent inhibitor of transferase activity found was galactinol, an inositol- 
cr-D-galactopyranoside. Myo-inositol is glycosidically linked at its L-3 position to the 
galactose. The L-1 position is the one phosphorylated in phosphatidyl inositol, while 
the L-3 (D-1) position retains the phosphate group after cyclization of ~-glucose-6- 
phosphate (EISENBERG, 1967). Galactinol was isolated from sugar beets (KABAT, 
MACDONALD, BALLOU and FISCHER, 1946) and enzymes which form it from myo- 
inositol and UDP-galactose are present in plants (FRYDMAN and NEUFELD, 1963). Its 
function is unknown. It is reported here for the first time to have an inhibitor property. 
Another compound substituted in the L-3 position, myo-inositol-~-3-phosphate, 
inhibited the enzyme more than the other monophosphates. All of the myo-inositol 
monophosphates were tested as substrates, but none substituted for myo-inositol. For 
brain at least, inositol monophosphate does not therefore seem to provide an alternate 
pathway for phosphatidyl inositol phosphate. The finding that none of the inositol 
monophosphates served as substrates does indicate, however, that the microsomal 
enzyme preparation is relatively free of phosphatases which would liberate inositol 
to be used as a substrate. EISENBERG, BOLDEN and LOEWUS (1964) found a very active 
inositol phosphatase in the supernatant fraction of testis homogenates. 
Studies on the brain transferase with galactose and galactitol gave no evidence of 
inhibition of incorporation of myo-inositol into lipids. Further investigation was 
prompted by the recently reported studies of WELLS and WELLS (1967) with rats on 
high galactose diets. They found that galactitol inhibited both the synthesis of inositol 
from glucose and the incorporation of inositol into phospholipid in viva In their 
studies, the incorporation of [2-14C]inositol into lipids was investigated in vitro by 
incubating a microsomal fraction from rat brain with CTP and phosphatidic acid. 
WELLS and WELLS (1967) thus measured the combined activity of CTP: phosphatid- 
ate-cytidyl transferase and CDP-diglyceride : inositol transferase. In the presence of 
1.06 x 1W M-galactitol, the incorporation of 4.16 x lo4 M-inositol was inhibited 
by 50 per cent. Evidence for competitive inhibition was obtained. In our assay for 
CDP-diglyceride : inositol transferase in brain, only 5 per cent inhibition was observed 
with high concentrations of galactitol. Galactose caused a similar inhibition; this 
suggests a non-specific effect. It is possible that the inhibitory effect of galactitol is 
dependent on assay conditions, that a different enzyme is inhibited by galactitol 
(presumably CTP:phosphatidate transferase), or that a species or age dependency 
exists with respect to galactitol inhibition. Also, since the assay of WELLS and WELLS 
(1967) uses incorporation of labelled inositol into lipid, the incorporation observed 
may include inositol- phosphatidyl inositol exchange (PAULUS and KENNEDY, 1960) 
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and galactitol could inhibit this exchange rather than de no00 synthesis of phosphatidyl 
inositol. 
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